Literature DB >> 8536460

Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas.

J C Kim1, S C Tseng.   

Abstract

After n-heptanol removal of the total corneal epithelium and a limbal lamellar keratectomy, 23 rabbit eyes developed features of limbal stem cell deficiency including conjunctival epithelial ingrowth, vascularization and chronic inflammation. One month later, 10 control eyes received a total keratectomy, and 13 experimental eyes received additional transplantation of glycerin-preserved human amniotic membrane. In 3 months of follow-up, all control corneas were revascularized to the center with granuloma and retained a conjunctival epithelial phenotype. In contrast, five corneas in the experimental group became clear with either minimal or no vascularization; the rest had either mid peripheral (n = 5) or total (n = 3) vascularization and cloudier stroma. The success of corneal surface reconstruction correlated with the return of a cornea-like epithelial phenotype and the preservation of amniotic membrane, whereas the failure maintained a conjunctival epithelial phenotype and the amniotic membrane was either partially degraded or covered by host fibrovascular stroma. These results suggest that measures taken to facilitate epithelialization without allowing host fibrovascular ingrowth onto the amniotic membrane might prove this procedure clinically useful for ocular surface reconstruction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8536460

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  119 in total

1.  Amniotic membrane transplantation for severe neurotrophic corneal ulcers.

Authors:  H J Chen; R T Pires; S C Tseng
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

2.  Amniotic membrane transplantation for necrotising conjunctival ulceration following subconjunctival atropine injection.

Authors:  K Y Seo; C Y Kim; J H Lee; J B Lee; E K Kim
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

3.  Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction.

Authors:  M Ueta; M-N Kweon; Y Sano; C Sotozono; J Yamada; N Koizumi; H Kiyono; S Kinoshita
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

4.  Transplantation of cultivated autologous oral mucosal epithelial cells in patients with severe ocular surface disorders.

Authors:  T Nakamura; T Inatomi; C Sotozono; T Amemiya; N Kanamura; S Kinoshita
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

5.  [Corneal wound healing. II. Treatment of disorders of wound healing].

Authors:  P W Rieck; U Pleyer
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

6.  Comparison of conjunctival autograft transplantation and amniotic membrane transplantation for pterygium: a meta-analysis.

Authors:  Meiyan Li; Min Zhu; Yongfu Yu; Lan Gong; Naiqing Zhao; Mark J Robitaille
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-09-21       Impact factor: 3.117

7.  Cultured corneal epithelia for ocular surface disease.

Authors:  I R Schwab
Journal:  Trans Am Ophthalmol Soc       Date:  1999

8.  Temporary amniotic membrane patch for the treatment of primary pterygium: mechanisms of reducing the recurrence rate.

Authors:  Juan Ye; Koung Hoon Kook; Ke Yao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-17       Impact factor: 3.117

Review 9.  Critical appraisal of ex vivo expansion of human limbal epithelial stem cells.

Authors:  S C G Tseng; S-Y Chen; Y-C Shen; W-L Chen; F-R Hu
Journal:  Curr Mol Med       Date:  2010-12       Impact factor: 2.222

10.  Novel implantable composite biomaterial by fibrin glue and amniotic membrane for ocular surface reconstruction.

Authors:  Mingming Cai; Jie Zhang; Lili Guan; Min Zhao
Journal:  J Mater Sci Mater Med       Date:  2015-03-13       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.